Evangelos Cholongitas, George V. Papatheodoridis, Paola Zappoli, Athanasios Giannakopoulos, David Patch, Laura Marelli, Vibhakorn Shusang, George Kalambokis, Graham Shirling, Nancy Rolando, A. K. Burroughs – 29 March 2007 – Combined disparity of human leukocyte antigen (HLA)‐DR and ‐DQ between mother and fetus is associated with less severe ulcerative colitis (UC) during pregnancy. We evaluated whether donor‐recipient HLA disparity after liver transplantation (LT) affects UC in patients with primary sclerosing cholangitis (PSC).

Jeremy R. Parfitt, Paul Marotta, Mohammed AlGhamdi, William Wall, Anand Khakhar, Neville G. Suskin, Douglas Quan, Vivian McAllister, Cam Ghent, Mark Levstik, Carolyn McLean, Subrata Chakrabarti, Bertha Garcia, David K. Driman – 29 March 2007 – Milan and University of California at San Francisco (UCSF) criteria are used to select patients with hepatocellular carcinoma (HCC) for liver transplantation (LT). Recurrent HCC is a significant cause of death. There is no widely accepted pathological assessment strategy to predict recurrent HCC after transplantation.

Zhen Fan Yang, Patricia Ngai, Chi Keung Lau, David W. Ho, Ka Ho Tam, Chi Tat Lam, Ronnie T. Poon, Sheung Tat Fan – 29 March 2007 – This study aims to investigate the potential role of endogenous interleukin (IL)‐10 in long‐term liver allograft survival induced by delayed immunosuppression (FK506 days 2‐7). Liver transplantation was performed by using Dark Agouti and Lewis rats as donors and recipients, respectively. The delayed immunosuppression protocol induced indefinite allograft survival.

Zhen Fan Yang, David Wing Yuen Ho, Patricia Ngai, Chi Keung Lau, Yi Zhao, Ronnie Tung Ping Poon, Sheung Tat Fan – 29 March 2007 – The present study aims to investigate the potential therapeutic role of interleukin‐10 (IL‐10) in small‐for‐size liver transplantation. A syngenic rat orthotopic liver transplantation model was performed using either whole or 40% liver volume of Lewis rats as grafts according to the experimental design. IL‐10 was given to the 40% grafts right after reperfusion, and also at 24 and 48 hours after transplantation.

Kristin L. Mekeel, Max R. Langham, Regino Gonzalez‐Peralta, Shiro Fujita, Alan W. Hemming – 29 March 2007 – Severe liver disease is an unusual but potentially fatal complication of sickle‐cell disease (SCD). Liver transplantation has been complicated by ongoing SCD and thrombosis. We reviewed 214 pediatric transplants done at our institution from 1990 to 2005. Three patients were transplanted for complications of SCD, including intrahepatic cholestasis and viral hepatitis. Overall patient and graft survival was 66%. One patient died after 6 years from a subdural hematoma.

Lawrence S. Friedman – 29 March 2007

Maud Bessems, Benedict M. Doorschodt, Joe L.P. Kolkert, Reeta L. Vetelainen, Arlene K. van Vliet, Heleen Vreeling, Jan van Marle, Thomas M. van Gulik – 29 March 2007 – Liver grafts are frequently discarded due to steatosis. Steatotic livers can be classified as suboptimal and deteriorate rapidly during hypothermic static preservation, often resulting in graft nonfunction. Hypothermic machine perfusion (MP) has been introduced for preservation of donor livers instead of cold storage (CS), resulting in superior preservation outcomes.

Xavier Forns, José A. Carrión, Miquel Navasa, Juan Carlos García‐Pagan, Miquel Bruguera, Jaume Bosch – 29 March 2007

Ian P.J. Alwayn, Robert J. Porte – 29 March 2007

Edson Abdala, Carlos Eduardo Sandoli Baía, Sérgio Mies, Paulo Celso Bosco Massarollo, Norma de Paula Cavalheiro, Vania Regina Mollo Baía, Conceição Aparecida Félix Inácio, Henry Corazza Sef, Antonio Alci Barone – 29 March 2007 – The aim of this study was to evaluate the bacterial translocation in liver transplantation (LT), comparing the conventional and the piggyback methods. A total of 32 patients were randomized into the 2 groups. Samples of blood were collected from the radial artery, portal vein (PV) and hepatic vein (HV), in up to 120 minutes postreperfusion.